Arpita Nag

Alexion, AstraZeneca Rare Disease, Boston, MA, USA

Poster(s):

• (A-121) Real-World Effectiveness of Ravulizumab in Adults With aHUS who Switched to Ravulizumab Within 3 Months of Eculizumab Treatment (aHUS IMPACT)
  Sunday, August 24, 2025

  12:00 PM - 1:30 PM ET